Literature DB >> 22889248

Delayed diagnosis of developmental dislocation of the hip: the Western Australian experience.

Ryan Lisle1, Michelle Boekelaar, Katherine Stannage, Colin Whitewood.   

Abstract

BACKGROUND: A delay in the diagnosis of developmental dislocation of the hip has many long-term consequences. This retrospective study was undertaken in order to establish an incidence of late-presenting developmental dislocation of the hip in Western Australia, and investigate possible causes for missed diagnoses.
METHOD: Data were collected retrospectively from 1 January to 31 December 2010. Theatre records were searched for operative descriptions including the words 'arthrogram hip', 'EUA hip', 'closed reduction hip', 'open reduction hip' and 'spica'. Medical records were checked to establish the demographic details and background history of cases identified. Delayed diagnosis of developmental dysplasia of the hip (DDH) was defined as a dislocated hip requiring operative reduction, diagnosed at age greater than 3 months.
RESULTS: Seventeen children with 21 dislocated hips were identified. Age at diagnosis ranged from 6 months to 5 years. Girls accounted for 88.2% (15/17) and the left hip was involved two-thirds of the time (14/21). Bilateral dislocations were found in four children.
CONCLUSION: This study has identified an incidence of late-presenting developmental hip dislocation of approximately three times the previously established rate. Possible reasons for this are explored. Additional retrospective audit is now underway, and changes are already in place to ensure that infants with DDH born in Western Australia are identified and treated as early as possible.
© 2012 The Authors. ANZ Journal of Surgery © 2012 Royal Australasian College of Surgeons.

Entities:  

Mesh:

Year:  2012        PMID: 22889248     DOI: 10.1111/j.1445-2197.2012.06110.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  6 in total

Review 1.  Screening of Newborns and Infants for Developmental Dysplasia of the Hip: A Systematic Review.

Authors:  Ritesh Arvind Pandey; Ashok N Johari
Journal:  Indian J Orthop       Date:  2021-05-02       Impact factor: 1.251

2.  Developmental dysplasia of the hip: incidence and treatment outcomes in the Southeast of Ireland.

Authors:  N Phelan; J Thoren; C Fox; B J O'Daly; J O'Beirne
Journal:  Ir J Med Sci       Date:  2014-05-31       Impact factor: 1.568

3.  Developmental dysplasia of the hip: why are we still operating on them? A plea for institutional newborn clinical screening.

Authors:  Wu Chean Lee; Sumanth Kumar Gera; Arjandas Mahadev
Journal:  Singapore Med J       Date:  2018-05-18       Impact factor: 1.858

4.  Increasing expression of substance P and calcitonin gene-related peptide in synovial tissue and fluid contribute to the progress of arthritis in developmental dysplasia of the hip.

Authors:  Hui Wang; Xiang Zhang; Ji-Ye He; Xin-Feng Zheng; De Li; Zheng Li; Jun-Feng Zhu; Chao Shen; Gui-Quan Cai; Xiao-Dong Chen
Journal:  Arthritis Res Ther       Date:  2015-01-12       Impact factor: 5.156

5.  Incidence of Neonatal Developmental Dysplasia of the Hip and Late Detection Rates Based on Screening Strategy: A Systematic Review and Meta-analysis.

Authors:  Ilari Kuitunen; Mikko M Uimonen; Marjut Haapanen; Reijo Sund; Ilkka Helenius; Ville T Ponkilainen
Journal:  JAMA Netw Open       Date:  2022-08-01

6.  Increasing substance P levels in serum and synovial tissues from patients with developmental dysplasia of the hip (DDH).

Authors:  Hui Wang; Xin-Feng Zheng; Xiang Zhang; Zheng Li; Chao Shen; Jun-Feng Zhu; Yi-Min Cui; Xiao-Dong Chen
Journal:  BMC Musculoskelet Disord       Date:  2014-03-19       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.